title: Performance on the continuous performance test in children with ADHD is associated with sleep efficiency.
abstract: OBJECTIVE
  To examine whether the level of sleep efficiency of children diagnosed with ADHD moderates their performance on the Continuous Performance Test (CPT) while receiving a placebo and while receiving methylphenidate (MPH).
  
  
  METHODS
  Nightly sleep actigraphic assessment during a double-blind, placebo-controlled, crossover clinical study (1 week of 0.5 mg/kg MPH; 1 week of placebo) were obtained on 37 children between 6 and 12 years of age with a DSM-IV diagnosis of ADHD. Subjects were divided into 2 groups based on the mean sleep efficiency score during the placebo condition, with subjects above and below the mean placed in the Poor Sleep Group (PSG) and Good Sleep Group (GSG), respectively.
  
  
  METHODS
  Vigilance testing was conducted in the laboratory; sleep was assessed in the home.
  
  
  METHODS
  Sleep was monitored using actigraphy for 2 weeks. In addition, parents were asked to complete nightly sleep logs and a sleep questionnaire. The Conners' Continuous Performance Test (CPT) was used to assess vigilance.
  
  
  RESULTS
  Significant interaction of Sleep Group with Medication was found on 1 CPT factor.
  
  
  CONCLUSIONS
  The findings of the present study support the hypothesis that sleep moderates performance on CPT in children with ADHD while receiving placebo or MPH.
authors: Douglas Mental Health University Institute and McGill University, Montreal, Canada. reut.gruber@douglas.mcgill.ca
authors: Reut
authors: R
authors: Gruber
authors: Natalie
authors: N
authors: Grizenko
authors: George
authors: G
authors: Schwartz
authors: Johanne
authors: J
authors: Bellingham
authors: Rosherrie
authors: R
authors: Guzman
authors: Ridha
authors: R
authors: Joober
mesh_terms: D001143:Arousal / Q000187:drug effects*; D001288:Attention / Q000187:drug effects*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D018592:Cross-Over Studies; D006970:Disorders of Excessive Somnolence / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D010364:Pattern Recognition, Visual / Q000187:drug effects; D017286:Polysomnography / Q000187:drug effects*; D011597:Psychomotor Performance / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects; D012892:Sleep Deprivation / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D014851:Wakefulness / Q000187:drug effects
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate
references: Acta Paediatr. 1992 Aug;81(8):618-24
references: 1392387
references: J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):28-38
references: 10638065
references: Psychol Bull. 1983 Nov;94(3):446-71
references: 6657825
references: Psychopharmacology (Berl). 2002 Nov;164(3):277-84
references: 12424551
references: Dev Neuropsychol. 2005;27(1):107-33
references: 15737944
references: J Am Acad Child Adolesc Psychiatry. 2001 Apr;40(4):409-18
references: 11314566
references: Pediatr Neurol. 1998 Mar;18(3):244-50
references: 9568922
references: J Abnorm Child Psychol. 2003 Oct;31(5):543-54
references: 14561061
references: Sleep. 2006 Feb;29(2):232-9
references: 16494091
references: J Abnorm Child Psychol. 1998 Aug;26(4):279-91
references: 9700520
references: Sleep Med Rev. 2004 Oct;8(5):379-402
references: 15336238
references: J Child Psychol Psychiatry. 1996 Nov;37(8):971-87
references: 9119944
references: Int J Psychophysiol. 2005 Oct;58(1):21-33
references: 15936104
references: Neuropsychopharmacology. 1989 Jun;2(2):153-64
references: 2742729
references: Sleep. 2004 Mar 15;27(2):261-6
references: 15124720
references: Psychopharmacology (Berl). 1993;111(1):1-16
references: 7870923
references: Psychopharmacol Bull. 1974 Oct;10(4):36-7
references: 4431868
references: Exp Clin Psychopharmacol. 2004 Aug;12(3):180-9
references: 15301635
references: Biol Psychiatry. 2005 Jun 1;57(11):1424-35
references: 15950017
references: Clin Electroencephalogr. 1998 Jan;29(1):37-42
references: 9472424
references: Exp Clin Psychopharmacol. 1999 May;7(2):145-50
references: 10340154
references: Psychopharmacol Bull. 1985;21(4):714-1124
references: 3911249
references: Exp Clin Psychopharmacol. 1997 Nov;5(4):344-52
references: 9386961
references: Mov Disord. 1999 Nov;14(6):1000-7
references: 10584676
references: Sleep. 2003 May 1;26(3):342-92
references: 12749557
references: Pediatrics. 2003 Mar;111(3):554-63
references: 12612236
references: Biol Psychiatry. 2005 Jun 1;57(11):1248-55
references: 15949995
references: Dev Sci. 2005 Mar;8(2):122-31
references: 15720370
references: J Abnorm Child Psychol. 1998 Aug;26(4):257-68
references: 9700518
references: J Child Psychol Psychiatry. 2000 Sep;41(6):803-12
references: 11039692
references: Clin Neurophysiol. 2003 Feb;114(2):171-83
references: 12559224
references: J Dev Behav Pediatr. 2005 Aug;26(4):312-22
references: 16100507
references: Sleep. 2005 Jan;28(1):113-21
references: 15700727